Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of PLX will rise by +4.07% over the next 2 Weeks and hit $3.02 by Wednesday, February 18, 2026. In that time frame, PLX's share price is expected to range between $2.91 and $3.14.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Feb 19, 2026 | 2.99 | 3.13 | 3.27 |
| Feb 18, 2026 | 2.97 | 3.12 | 3.26 |
| Feb 17, 2026 | 3.01 | 3.16 | 3.31 |
| Feb 16, 2026 | 3.01 | 3.16 | 3.30 |
| Feb 13, 2026 | 2.93 | 3.08 | 3.23 |
| Feb 12, 2026 | 2.89 | 3.02 | 3.17 |
| Feb 11, 2026 | 2.85 | 3.01 | 3.14 |
| Feb 10, 2026 | 2.90 | 3.05 | 3.20 |
| Feb 9, 2026 | 2.90 | 3.05 | 3.19 |
| Feb 6, 2026 | 2.84 | 2.97 | 3.12 |
PLX shares rose +0.34% in Thursday, February 5, 2026's trading session, rising from a previous close of $2.90 to move at $2.91. The stock demonstrated notable intraday movement (see PLX's key stats for a full breakdown), fluctuating between $2.85 and $3.03, a +6.14% trading range. While recent weeks have seen some volatility, PLX has managed to secure a +39.90% gain over the past 2 weeks. The upward price movement was accompanied by decreased trading volume, with approximately 2.39M shares changing hands, 190.61K fewer than the previous session. This amounted to $6.95M in total market activity.
Will PLX Continue Its Upward Trend?
According to analyst ratings and projections for PLX, Protalix BioTherapeutics, Inc. shares are anticipated to increase by +11.09%, potentially reaching $3.27 per share by February 19, 2026. Short-term technical indicators currently suggest a neutral sentiment for PLX. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 19 positive trading days within the past 30 sessions. Based on the PLX stock forecast, now is a good time to buy PLX stock because its current trading price is -7.14% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on PLX covering social and institutional perspectives.
PLX Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into PLX's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 79.37% to 90.66%) indicate the stock is in a strong bullish momentum phase. The 50-day RSI, at 64.31%, suggests strong medium-term momentum. However, the 100-day RSI, at 57.79%, maintains a neutral outlook for the long term. Insights into PLX's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Protalix BioTherapeutics Short-Term Forecasts
PLX Forecast For Next 5 Days
Our algorithm anticipates Protalix BioTherapeutics (PLX) stock could hit $2.83 by Feb 12, 2026. This represents a -2.75% fall from today's price, following a -2.38% change over the past five days.
PLX Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Protalix BioTherapeutics, Inc. (PLX) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $2.88, which would mean a -1.03% decrease from the current price of $2.91. Projections for this period range from a high of $3.43 to a low of $2.49.
PLX Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Protalix BioTherapeutics's price over the next three months point to a rise. PLX stock is expected to peak at $21.46 on Apr 29, 2026 after potentially dipping to $17.29 on Apr 10, 2026. On average, PLX is likely to trade around $19.56 in the coming 90 days.
Protalix BioTherapeutics Stock Forecast 2025
Based on our predictive models, Protalix BioTherapeutics (PLX) is expected to trade between $14.62 and $34.02 throughout 2026. This would result in an average price of $20.13, potentially offering investors a +591.75% return from current levels.
Protalix BioTherapeutics, Inc. Monthly Forecast 2026–2027
February 2026
According to our latest forecast models, Protalix BioTherapeutics, Inc. (PLX) is positioned to show a strong performance in February 2026. The price is predicted to move between $19.93 and $21.32, settling at an average of $20.90. This could translate to a +618.21% gain.
March 2026
Based on current market signals, Protalix BioTherapeutics, Inc. is projected to trend march 2026. We forecast a trading range from $17.76 to $20.63, with a likely average price of $19.12. Investors could expect a potential return of +557.04%.
April 2026
Our predictive algorithms indicate Protalix BioTherapeutics, Inc. stock may see a shift in April 2026. The expected range spans $17.29–$21.46, with an average target of $18.90. This represents a positive outlook and a possible gain of +549.48%.
May 2026
Analyzing established trends, Protalix BioTherapeutics, Inc. looks set to move in May 2026. Projections place the stock between $14.67 and $21.26, averaging around $17.61. This suggests a +505.15% gain from current levels.
June 2026
Market indicators suggest Protalix BioTherapeutics, Inc. could experience notable changes during June 2026. Prices could fluctuate within $15.11 to $20.75, with a midpoint forecast of $18.06. The stock might deliver a +520.62% gain.
July 2026
Forecasting for July 2026, models estimate that Protalix BioTherapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $17.12 and $22.94, averaging $19.68. This signals a positive trajectory with potential returns around +576.29%.
August 2026
According to our latest forecast models, Protalix BioTherapeutics, Inc. (PLX) is positioned to show a strong performance in August 2026. The price is predicted to move between $15.70 and $23.62, settling at an average of $19.29. This could translate to a +562.89% gain.
September 2026
Based on current market signals, Protalix BioTherapeutics, Inc. is projected to trend september 2026. We forecast a trading range from $14.62 to $27.07, with a likely average price of $19.76. Investors could expect a potential return of +579.04%.
October 2026
Our predictive algorithms indicate Protalix BioTherapeutics, Inc. stock may see a shift in October 2026. The expected range spans $16.19–$29.14, with an average target of $22.13. This represents a positive outlook and a possible gain of +660.48%.
November 2026
Analyzing established trends, Protalix BioTherapeutics, Inc. looks set to move in November 2026. Projections place the stock between $14.91 and $30.33, averaging around $22.41. This suggests a +670.10% gain from current levels.
December 2026
Market indicators suggest Protalix BioTherapeutics, Inc. could experience notable changes during December 2026. Prices could fluctuate within $14.86 to $34.02, with a midpoint forecast of $23.65. The stock might deliver a +712.71% gain.
January 2027
Forecasting for January 2027, models estimate that Protalix BioTherapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $13.42 and $34.44, averaging $23.16. This signals a positive trajectory with potential returns around +695.88%.
February 2027
According to our latest forecast models, Protalix BioTherapeutics, Inc. (PLX) is positioned to show a strong performance in February 2027. The price is predicted to move between $12.85 and $32.74, settling at an average of $22.35. This could translate to a +668.04% gain.
PLX's history of dividends and stock splits also plays a role in long-term investor confidence.